Comments on Thrombosis After Vaccination: The Leader Sequence of the Spike Protein Might Be Responsible for Thrombosis and Antibody-Mediated Thrombocytopenia

Abrams C , and Shattil SJ . Immunological detection of activated platelets in clinical disorders. Thromb Haemost, 1991; 65:467–473.

Ali MAM , and Spinler SA . COVID-19 and thrombosis: from bench to bedside. Trends Cardiovasc Med, 2021; 31:143–160.

Althaus K , Zlamal J , and Bakchoul T . Antibody-mediated platelet activation in COVID-19: a coincidence or a new mechanism of the dysregulated coagulation system?. J Thromb Haemost, 2021; 19:1171–1173.

Bestle D , Heindl MR , Limburg H , et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci Alliance, 2020; 3:e202000786.

Bhattacharjee S , and Banerjee M . Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr Clin Med, 2020; 90:1–11.

Bos R , Rutten L , van der Lubbe JEM , et al. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. NPJ Vaccines, 2020; 5:91.

Bye A , Hoepel W , Mitchell JL , et al. Aberrant glycosylation of anti-SARS-CoV-2 IgG is a pro-thrombotic stimulus for platelets. Blood, 2021; 138:1481–1489.

Chiang K , Raghavan R , and Gupta A . SARS-CoV-2 vaccination induced cerebral venous sinus thrombosis: do megakaryocytes, platelets and lipid mediators make up the orchestra?. Free Neuropathol, 2021; 2:18.

Cohen CJ , Xiang ZQ , Gao GP , et al. Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor. J Gen Virol, 2002; 83:151–155.

Corbett KS , Flynn B , Foulds KE , et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N Engl J Med, 2020; 383:1544–1555.

Gasbarri M , V'kovski P , Torriani G , et al. SARS-CoV-2 inhibition by sulfonated compounds. Microorganisms, 2020; 8:1894.

Giannis D , Ziogas IA , and Gianni P . Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol, 2020; 127:104362.

Greinacher A , Selleng K , Mayerle J , et al. Anti-SARS-CoV-2 spike protein and anti-platelet factor 4 antibody responses induced by COVID-19 disease and ChAdOx1 nCov-19 vaccination. Research Square 2021 [Epub ahead of print]; DOI: 10.21203/rs.3.rs-404769/v1.

Greinacher A , Thiele T , Warkentin TE , et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med, 2021; 384:2092–2101.

Jerjes-Sánchez C . Thrombolysis in Pulmonary Embolism. Cham (Denmark): Springer, 2015.

Joly BS , Coppo P , and Veyradier A . Thrombotic thrombocytopenic purpura. Blood, 2017; 129:2836–2846.

Jones I , and Roy P . Sputnik V COVID-19 vaccine candidate appears safe and effective. Lancet, 2021; 397:642–643.

Letarov AV , Babenko VV , and Kulikov EE . Free SARS-CoV-2 spike protein S1 particles may play a role in the pathogenesis of COVID-19 infection. Biochemistry (Mosc), 2021; 86:257–261.

Muir KL , Kallam A , Koepsell SA , and Gundabolu K . Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N Engl J Med, 2021; 384:1964–1965.

Mulligan MJ , Lyke KE , Kitchin N , et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature, 2020; 586:589–593.

O'Neil KM . Role of complement in antiphospholipid antibody-mediated thrombosis. Curr Rheumatol Rep, 2007; 9:205–211.

Perico L , Benigni A , Casiraghi F , Ng LFP , Renia L , and Remuzzi G . Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol, 2021; 17:46–64.

Saupe F , Huijbers EJ , Hein T , et al. Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters. FASEB J, 2015; 29:3253–3262.

schVerdecchia P , Cavallini C , Spanevello A , et al. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med, 2020; 76:14–20.

Scully M , Singh D , Lown R , et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med, 2021; 384:2202–2211.

Wang JY , Song WT , Li Y , et al. Improved expression of secretory and trimeric proteins in mammalian cells via the introduction of a new trimer motif and a mutant of the tPA signal sequence. Appl Microbiol Biotechnol, 2011; 91:731–740.

Watanabe Y , Mendonça L , Allen ER , et al. Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine. ACS Cent Sci, 2021; 7:594–602.

Xia X . Domains and functions of spike protein in Sars-Cov-2 in the context of vaccine design. Viruses, 2021; 13:109.

Zhang S , Liu Y , Wang X , et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol, 2020; 13:120.